CMP - Cipla Medpro South Africa Limited - Dealing in securities by a director
CMP
CMP
CMP - Cipla Medpro South Africa Limited - Dealing in securities by a director
CIPLA MEDPRO SOUTH AFRICA LIMITED
(formerly Enaleni Pharmaceuticals Limited)
(Incorporated in the Republic of South Africa)
(Registration number 2002/018027/06)
(ISIN Number: ZAE000128179 Share Code: CMP)
("Cipla Medpro" or "the Company")
DEALING IN SECURITIES BY A DIRECTOR
In terms of paragraph 3.63 - 3.65 of the JSE Limited Listings Requirements, the
following information relates to the dealing in securities by directors of Cipla
Medpro:
Executive director: J S Smith
Company: Cipla Medpro
Number of shares: 856 617
Price: R3.68 per share
Value of transaction: R3 152 350.56
Extent of interest: Indirect beneficial
Date of transaction: 21 October 2009
Nature of transaction: Sale of shares from the JS Pharm Trust
of which Mr J S Smith is a beneficiary
to The Generic Pharm Trust in terms of
an historical transaction concluded at
fair value.
Written clearance to deal obtained: Yes
Durban
23 October 2009
Sponsor
Nedbank Capital
Date: 23/10/2009 14:56:27 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
